Agrylin Capsule
Product Images NDC 54092-063

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Agrylin (NDC 54092-063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imprint (Agrylin 01)

Agrylin 0.5 mg oral capsules label shows the product name Agrylin and the active ingredient anagrelide hydrochloride. The label indicates the dosage form as capsules for oral use. It is produced by Takeda Pharmaceuticals America, Inc. The packaging is primarily white with sections of blue and orange.*

FDA Label Image

Chemical Structure (Agrylin 02)

Chemical structure diagram of anagrelide hydrochloride, the active ingredient in Agrylin 0.5 mg capsules. The structure shows the chlorinated bicyclic compound with associated hydrochloride and hydrate components.*

FDA Label Image

Figure 1 (Agrylin 03)

A line graph depicting the mean platelet count (x 10^3/µL) over time (weeks) in patients with thrombocytosis secondary to myeloproliferative disorders during anagrelide therapy. The graph shows a decrease in platelet count from about 1200 to around 500 over approximately 208 weeks of treatment, with the number of subjects at different time points noted below the x-axis.*

FDA Label Image

Principal Display Panel (0.5 mg Capsule Bottle Label)

Label for Agrylin (anagrelide hydrochloride) capsules, 0.5 mg strength, an oral platelet-reducing agent by Takeda Pharmaceuticals America, Inc. The label indicates a package size of 100 capsules and includes storage instructions and ingredients list, alongside the product NDC 54092-063-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.